nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluticasone furoate—ABCB1—kidney cancer	0.324	1	CbGaD
Fluticasone furoate—ABCB1—Temsirolimus—kidney cancer	0.0686	0.134	CbGbCtD
Fluticasone furoate—CYP3A4—Everolimus—kidney cancer	0.0609	0.119	CbGbCtD
Fluticasone furoate—CYP3A4—Temsirolimus—kidney cancer	0.0411	0.0802	CbGbCtD
Fluticasone furoate—ABCB1—Pazopanib—kidney cancer	0.0361	0.0703	CbGbCtD
Fluticasone furoate—ABCB1—Dactinomycin—kidney cancer	0.033	0.0643	CbGbCtD
Fluticasone furoate—ABCB1—Gemcitabine—kidney cancer	0.0261	0.0509	CbGbCtD
Fluticasone furoate—ABCB1—Erlotinib—kidney cancer	0.0257	0.0502	CbGbCtD
Fluticasone furoate—ABCB1—Paclitaxel—kidney cancer	0.0236	0.046	CbGbCtD
Fluticasone furoate—CYP3A4—Pazopanib—kidney cancer	0.0216	0.0422	CbGbCtD
Fluticasone furoate—ABCB1—Sorafenib—kidney cancer	0.0209	0.0408	CbGbCtD
Fluticasone furoate—ABCB1—Vinblastine—kidney cancer	0.0207	0.0403	CbGbCtD
Fluticasone furoate—ABCB1—Vincristine—kidney cancer	0.0203	0.0396	CbGbCtD
Fluticasone furoate—ABCB1—Sunitinib—kidney cancer	0.017	0.0331	CbGbCtD
Fluticasone furoate—CYP3A4—Erlotinib—kidney cancer	0.0154	0.0301	CbGbCtD
Fluticasone furoate—CYP3A4—Paclitaxel—kidney cancer	0.0141	0.0275	CbGbCtD
Fluticasone furoate—ABCB1—Doxorubicin—kidney cancer	0.0127	0.0248	CbGbCtD
Fluticasone furoate—CYP3A4—Sorafenib—kidney cancer	0.0125	0.0245	CbGbCtD
Fluticasone furoate—CYP3A4—Vinblastine—kidney cancer	0.0124	0.0241	CbGbCtD
Fluticasone furoate—CYP3A4—Vincristine—kidney cancer	0.0122	0.0237	CbGbCtD
Fluticasone furoate—CYP3A4—Sunitinib—kidney cancer	0.0102	0.0198	CbGbCtD
Fluticasone furoate—CYP3A4—Doxorubicin—kidney cancer	0.00761	0.0148	CbGbCtD
Fluticasone furoate—Amcinonide—ANXA1—kidney cancer	0.00184	0.487	CrCbGaD
Fluticasone furoate—NR3C1—urine—kidney cancer	0.000835	0.239	CbGeAlD
Fluticasone furoate—CYP3A4—urine—kidney cancer	0.000631	0.181	CbGeAlD
Fluticasone furoate—Vulvovaginal candidiasis—Doxorubicin—kidney cancer	0.000614	0.00406	CcSEcCtD
Fluticasone furoate—Nasopharyngitis—Sorafenib—kidney cancer	0.000612	0.00405	CcSEcCtD
Fluticasone furoate—Blood pressure increased—Paclitaxel—kidney cancer	0.00061	0.00404	CcSEcCtD
Fluticasone furoate—Dysphonia—Capecitabine—kidney cancer	0.000608	0.00403	CcSEcCtD
Fluticasone furoate—Conjunctivitis—Everolimus—kidney cancer	0.000591	0.00391	CcSEcCtD
Fluticasone furoate—Vulvovaginal mycotic infection—Doxorubicin—kidney cancer	0.00059	0.00391	CcSEcCtD
Fluticasone furoate—Nasopharyngitis—Sunitinib—kidney cancer	0.000589	0.0039	CcSEcCtD
Fluticasone furoate—Angioedema—Temsirolimus—kidney cancer	0.000584	0.00386	CcSEcCtD
Fluticasone furoate—Candida infection—Paclitaxel—kidney cancer	0.000582	0.00385	CcSEcCtD
Fluticasone furoate—Dexamethasone—ANXA1—kidney cancer	0.000578	0.153	CrCbGaD
Fluticasone furoate—Epistaxis—Everolimus—kidney cancer	0.000574	0.0038	CcSEcCtD
Fluticasone furoate—Conjunctivitis—Erlotinib—kidney cancer	0.00057	0.00377	CcSEcCtD
Fluticasone furoate—Cough—Temsirolimus—kidney cancer	0.000557	0.00369	CcSEcCtD
Fluticasone furoate—Epistaxis—Erlotinib—kidney cancer	0.000553	0.00366	CcSEcCtD
Fluticasone furoate—Bronchitis—Sunitinib—kidney cancer	0.000548	0.00363	CcSEcCtD
Fluticasone furoate—Pharyngitis—Vinblastine—kidney cancer	0.000544	0.0036	CcSEcCtD
Fluticasone furoate—Herpes simplex—Capecitabine—kidney cancer	0.000543	0.0036	CcSEcCtD
Fluticasone furoate—Pharyngitis—Everolimus—kidney cancer	0.000542	0.00359	CcSEcCtD
Fluticasone furoate—Connective tissue disorder—Everolimus—kidney cancer	0.000536	0.00355	CcSEcCtD
Fluticasone furoate—Ulcer—Capecitabine—kidney cancer	0.000529	0.0035	CcSEcCtD
Fluticasone furoate—Cataract—Capecitabine—kidney cancer	0.000526	0.00348	CcSEcCtD
Fluticasone furoate—Cough—Pazopanib—kidney cancer	0.000525	0.00348	CcSEcCtD
Fluticasone furoate—Anaphylactic shock—Temsirolimus—kidney cancer	0.000521	0.00345	CcSEcCtD
Fluticasone furoate—Infection—Temsirolimus—kidney cancer	0.000518	0.00343	CcSEcCtD
Fluticasone furoate—Connective tissue disorder—Erlotinib—kidney cancer	0.000518	0.00343	CcSEcCtD
Fluticasone furoate—Nervous system disorder—Temsirolimus—kidney cancer	0.000511	0.00338	CcSEcCtD
Fluticasone furoate—Eye disorder—Everolimus—kidney cancer	0.00051	0.00338	CcSEcCtD
Fluticasone furoate—Blood pressure increased—Capecitabine—kidney cancer	0.000501	0.00331	CcSEcCtD
Fluticasone furoate—Epistaxis—Sorafenib—kidney cancer	0.000498	0.0033	CcSEcCtD
Fluticasone furoate—Immune system disorder—Everolimus—kidney cancer	0.000493	0.00326	CcSEcCtD
Fluticasone furoate—Eye disorder—Erlotinib—kidney cancer	0.000492	0.00326	CcSEcCtD
Fluticasone furoate—Mediastinal disorder—Everolimus—kidney cancer	0.000492	0.00326	CcSEcCtD
Fluticasone furoate—Infection—Pazopanib—kidney cancer	0.000488	0.00323	CcSEcCtD
Fluticasone furoate—Nervous system disorder—Pazopanib—kidney cancer	0.000482	0.00319	CcSEcCtD
Fluticasone furoate—Epistaxis—Sunitinib—kidney cancer	0.000479	0.00317	CcSEcCtD
Fluticasone furoate—Candida infection—Capecitabine—kidney cancer	0.000478	0.00316	CcSEcCtD
Fluticasone furoate—Mediastinal disorder—Erlotinib—kidney cancer	0.000475	0.00314	CcSEcCtD
Fluticasone furoate—Visual disturbance—Paclitaxel—kidney cancer	0.000467	0.00309	CcSEcCtD
Fluticasone furoate—Connective tissue disorder—Sorafenib—kidney cancer	0.000466	0.00308	CcSEcCtD
Fluticasone furoate—Dyspnoea—Temsirolimus—kidney cancer	0.000465	0.00308	CcSEcCtD
Fluticasone furoate—Back pain—Everolimus—kidney cancer	0.00046	0.00304	CcSEcCtD
Fluticasone furoate—Connective tissue disorder—Sunitinib—kidney cancer	0.000448	0.00297	CcSEcCtD
Fluticasone furoate—Tremor—Everolimus—kidney cancer	0.000445	0.00295	CcSEcCtD
Fluticasone furoate—Back pain—Erlotinib—kidney cancer	0.000443	0.00294	CcSEcCtD
Fluticasone furoate—Dyspnoea—Pazopanib—kidney cancer	0.000438	0.0029	CcSEcCtD
Fluticasone furoate—Agitation—Everolimus—kidney cancer	0.000437	0.00289	CcSEcCtD
Fluticasone furoate—Angioedema—Everolimus—kidney cancer	0.000434	0.00287	CcSEcCtD
Fluticasone furoate—Pharyngitis—Dactinomycin—kidney cancer	0.000428	0.00284	CcSEcCtD
Fluticasone furoate—Immune system disorder—Sorafenib—kidney cancer	0.000428	0.00283	CcSEcCtD
Fluticasone furoate—Mediastinal disorder—Sorafenib—kidney cancer	0.000427	0.00283	CcSEcCtD
Fluticasone furoate—Eye disorder—Sunitinib—kidney cancer	0.000426	0.00282	CcSEcCtD
Fluticasone furoate—Palpitations—Everolimus—kidney cancer	0.00042	0.00278	CcSEcCtD
Fluticasone furoate—Cough—Everolimus—kidney cancer	0.000415	0.00274	CcSEcCtD
Fluticasone furoate—Body temperature increased—Temsirolimus—kidney cancer	0.000412	0.00273	CcSEcCtD
Fluticasone furoate—Immune system disorder—Sunitinib—kidney cancer	0.000412	0.00273	CcSEcCtD
Fluticasone furoate—Mediastinal disorder—Sunitinib—kidney cancer	0.000411	0.00272	CcSEcCtD
Fluticasone furoate—Cough—Erlotinib—kidney cancer	0.0004	0.00265	CcSEcCtD
Fluticasone furoate—Nasopharyngitis—Paclitaxel—kidney cancer	0.000396	0.00262	CcSEcCtD
Fluticasone furoate—Dysphonia—Doxorubicin—kidney cancer	0.000392	0.0026	CcSEcCtD
Fluticasone furoate—Infection—Everolimus—kidney cancer	0.000385	0.00255	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Temsirolimus—kidney cancer	0.000384	0.00254	CcSEcCtD
Fluticasone furoate—Back pain—Sunitinib—kidney cancer	0.000384	0.00254	CcSEcCtD
Fluticasone furoate—Nervous system disorder—Everolimus—kidney cancer	0.00038	0.00252	CcSEcCtD
Fluticasone furoate—Connective tissue disorder—Vincristine—kidney cancer	0.000379	0.00251	CcSEcCtD
Fluticasone furoate—Angioedema—Sorafenib—kidney cancer	0.000377	0.00249	CcSEcCtD
Fluticasone furoate—Infection—Erlotinib—kidney cancer	0.000372	0.00246	CcSEcCtD
Fluticasone furoate—Bronchitis—Paclitaxel—kidney cancer	0.000368	0.00244	CcSEcCtD
Fluticasone furoate—Nervous system disorder—Erlotinib—kidney cancer	0.000367	0.00243	CcSEcCtD
Fluticasone furoate—Pharyngitis—Gemcitabine—kidney cancer	0.000363	0.0024	CcSEcCtD
Fluticasone furoate—Angioedema—Sunitinib—kidney cancer	0.000363	0.0024	CcSEcCtD
Fluticasone furoate—Cough—Sorafenib—kidney cancer	0.00036	0.00238	CcSEcCtD
Fluticasone furoate—Connective tissue disorder—Gemcitabine—kidney cancer	0.00036	0.00238	CcSEcCtD
Fluticasone furoate—Migraine—Capecitabine—kidney cancer	0.000358	0.00237	CcSEcCtD
Fluticasone furoate—Diarrhoea—Temsirolimus—kidney cancer	0.000357	0.00236	CcSEcCtD
Fluticasone furoate—Triamcinolone—BCHE—kidney cancer	0.000354	0.0935	CrCbGaD
Fluticasone furoate—Herpes simplex—Doxorubicin—kidney cancer	0.00035	0.00232	CcSEcCtD
Fluticasone furoate—Mediastinal disorder—Vincristine—kidney cancer	0.000348	0.0023	CcSEcCtD
Fluticasone furoate—Cough—Sunitinib—kidney cancer	0.000346	0.00229	CcSEcCtD
Fluticasone furoate—Dyspnoea—Everolimus—kidney cancer	0.000346	0.00229	CcSEcCtD
Fluticasone furoate—Dizziness—Temsirolimus—kidney cancer	0.000345	0.00228	CcSEcCtD
Fluticasone furoate—Ulcer—Doxorubicin—kidney cancer	0.000341	0.00226	CcSEcCtD
Fluticasone furoate—Anaphylactic shock—Sorafenib—kidney cancer	0.000337	0.00223	CcSEcCtD
Fluticasone furoate—Diarrhoea—Pazopanib—kidney cancer	0.000336	0.00222	CcSEcCtD
Fluticasone furoate—Infection—Sorafenib—kidney cancer	0.000334	0.00221	CcSEcCtD
Fluticasone furoate—Dyspnoea—Erlotinib—kidney cancer	0.000334	0.00221	CcSEcCtD
Fluticasone furoate—Atrioventricular block—Doxorubicin—kidney cancer	0.000333	0.0022	CcSEcCtD
Fluticasone furoate—Clobetasol propionate—CYP1A1—kidney cancer	0.000332	0.0878	CrCbGaD
Fluticasone furoate—Conjunctivitis—Paclitaxel—kidney cancer	0.000332	0.0022	CcSEcCtD
Fluticasone furoate—Immune system disorder—Gemcitabine—kidney cancer	0.00033	0.00219	CcSEcCtD
Fluticasone furoate—Nervous system disorder—Sorafenib—kidney cancer	0.00033	0.00219	CcSEcCtD
Fluticasone furoate—Mediastinal disorder—Gemcitabine—kidney cancer	0.00033	0.00218	CcSEcCtD
Fluticasone furoate—Rash—Temsirolimus—kidney cancer	0.000329	0.00218	CcSEcCtD
Fluticasone furoate—Dermatitis—Temsirolimus—kidney cancer	0.000328	0.00217	CcSEcCtD
Fluticasone furoate—Headache—Temsirolimus—kidney cancer	0.000327	0.00216	CcSEcCtD
Fluticasone furoate—Nasopharyngitis—Capecitabine—kidney cancer	0.000325	0.00215	CcSEcCtD
Fluticasone furoate—Dizziness—Pazopanib—kidney cancer	0.000325	0.00215	CcSEcCtD
Fluticasone furoate—Back pain—Vincristine—kidney cancer	0.000325	0.00215	CcSEcCtD
Fluticasone furoate—Epistaxis—Paclitaxel—kidney cancer	0.000322	0.00213	CcSEcCtD
Fluticasone furoate—Infection—Sunitinib—kidney cancer	0.000322	0.00213	CcSEcCtD
Fluticasone furoate—Nervous system disorder—Sunitinib—kidney cancer	0.000318	0.0021	CcSEcCtD
Fluticasone furoate—Rash—Pazopanib—kidney cancer	0.00031	0.00205	CcSEcCtD
Fluticasone furoate—Nausea—Temsirolimus—kidney cancer	0.00031	0.00205	CcSEcCtD
Fluticasone furoate—Dermatitis—Pazopanib—kidney cancer	0.000309	0.00205	CcSEcCtD
Fluticasone furoate—Agitation—Vincristine—kidney cancer	0.000309	0.00204	CcSEcCtD
Fluticasone furoate—Back pain—Gemcitabine—kidney cancer	0.000308	0.00204	CcSEcCtD
Fluticasone furoate—Candida infection—Doxorubicin—kidney cancer	0.000308	0.00204	CcSEcCtD
Fluticasone furoate—Headache—Pazopanib—kidney cancer	0.000308	0.00204	CcSEcCtD
Fluticasone furoate—Body temperature increased—Everolimus—kidney cancer	0.000307	0.00203	CcSEcCtD
Fluticasone furoate—Infection—Dactinomycin—kidney cancer	0.000305	0.00202	CcSEcCtD
Fluticasone furoate—Pharyngitis—Paclitaxel—kidney cancer	0.000304	0.00201	CcSEcCtD
Fluticasone furoate—Bronchitis—Capecitabine—kidney cancer	0.000302	0.002	CcSEcCtD
Fluticasone furoate—Connective tissue disorder—Paclitaxel—kidney cancer	0.000301	0.00199	CcSEcCtD
Fluticasone furoate—Dyspnoea—Sorafenib—kidney cancer	0.0003	0.00199	CcSEcCtD
Fluticasone furoate—Body temperature increased—Erlotinib—kidney cancer	0.000296	0.00196	CcSEcCtD
Fluticasone furoate—Visual impairment—Paclitaxel—kidney cancer	0.000295	0.00195	CcSEcCtD
Fluticasone furoate—Nausea—Pazopanib—kidney cancer	0.000292	0.00193	CcSEcCtD
Fluticasone furoate—Dyspnoea—Sunitinib—kidney cancer	0.000289	0.00191	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Vinblastine—kidney cancer	0.000287	0.0019	CcSEcCtD
Fluticasone furoate—Eye disorder—Paclitaxel—kidney cancer	0.000286	0.00189	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Everolimus—kidney cancer	0.000286	0.00189	CcSEcCtD
Fluticasone furoate—Cough—Gemcitabine—kidney cancer	0.000278	0.00184	CcSEcCtD
Fluticasone furoate—Immune system disorder—Paclitaxel—kidney cancer	0.000277	0.00183	CcSEcCtD
Fluticasone furoate—Mediastinal disorder—Paclitaxel—kidney cancer	0.000276	0.00183	CcSEcCtD
Fluticasone furoate—Anaphylactic shock—Vincristine—kidney cancer	0.000274	0.00181	CcSEcCtD
Fluticasone furoate—Infection—Vincristine—kidney cancer	0.000272	0.0018	CcSEcCtD
Fluticasone furoate—Conjunctivitis—Capecitabine—kidney cancer	0.000272	0.0018	CcSEcCtD
Fluticasone furoate—Nervous system disorder—Vincristine—kidney cancer	0.000269	0.00178	CcSEcCtD
Fluticasone furoate—Urticaria—Sorafenib—kidney cancer	0.000267	0.00177	CcSEcCtD
Fluticasone furoate—Diarrhoea—Vinblastine—kidney cancer	0.000266	0.00176	CcSEcCtD
Fluticasone furoate—Body temperature increased—Sorafenib—kidney cancer	0.000266	0.00176	CcSEcCtD
Fluticasone furoate—Diarrhoea—Everolimus—kidney cancer	0.000265	0.00176	CcSEcCtD
Fluticasone furoate—Epistaxis—Capecitabine—kidney cancer	0.000264	0.00175	CcSEcCtD
Fluticasone furoate—Anaphylactic shock—Gemcitabine—kidney cancer	0.00026	0.00172	CcSEcCtD
Fluticasone furoate—Infection—Gemcitabine—kidney cancer	0.000258	0.00171	CcSEcCtD
Fluticasone furoate—Back pain—Paclitaxel—kidney cancer	0.000258	0.00171	CcSEcCtD
Fluticasone furoate—Dizziness—Vinblastine—kidney cancer	0.000257	0.0017	CcSEcCtD
Fluticasone furoate—Dizziness—Everolimus—kidney cancer	0.000256	0.0017	CcSEcCtD
Fluticasone furoate—Body temperature increased—Sunitinib—kidney cancer	0.000256	0.0017	CcSEcCtD
Fluticasone furoate—Diarrhoea—Erlotinib—kidney cancer	0.000256	0.00169	CcSEcCtD
Fluticasone furoate—Nervous system disorder—Gemcitabine—kidney cancer	0.000255	0.00169	CcSEcCtD
Fluticasone furoate—Tremor—Paclitaxel—kidney cancer	0.00025	0.00165	CcSEcCtD
Fluticasone furoate—Pharyngitis—Capecitabine—kidney cancer	0.000249	0.00165	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Sorafenib—kidney cancer	0.000248	0.00164	CcSEcCtD
Fluticasone furoate—Dizziness—Erlotinib—kidney cancer	0.000247	0.00164	CcSEcCtD
Fluticasone furoate—Connective tissue disorder—Capecitabine—kidney cancer	0.000247	0.00164	CcSEcCtD
Fluticasone furoate—Agitation—Paclitaxel—kidney cancer	0.000245	0.00162	CcSEcCtD
Fluticasone furoate—Rash—Everolimus—kidney cancer	0.000245	0.00162	CcSEcCtD
Fluticasone furoate—Dermatitis—Everolimus—kidney cancer	0.000244	0.00162	CcSEcCtD
Fluticasone furoate—Headache—Vinblastine—kidney cancer	0.000244	0.00161	CcSEcCtD
Fluticasone furoate—Angioedema—Paclitaxel—kidney cancer	0.000244	0.00161	CcSEcCtD
Fluticasone furoate—Headache—Everolimus—kidney cancer	0.000243	0.00161	CcSEcCtD
Fluticasone furoate—Body temperature increased—Dactinomycin—kidney cancer	0.000242	0.0016	CcSEcCtD
Fluticasone furoate—Visual impairment—Capecitabine—kidney cancer	0.000242	0.0016	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Sunitinib—kidney cancer	0.000239	0.00158	CcSEcCtD
Fluticasone furoate—Rash—Erlotinib—kidney cancer	0.000236	0.00156	CcSEcCtD
Fluticasone furoate—Dermatitis—Erlotinib—kidney cancer	0.000236	0.00156	CcSEcCtD
Fluticasone furoate—Palpitations—Paclitaxel—kidney cancer	0.000236	0.00156	CcSEcCtD
Fluticasone furoate—Eye disorder—Capecitabine—kidney cancer	0.000235	0.00155	CcSEcCtD
Fluticasone furoate—Headache—Erlotinib—kidney cancer	0.000234	0.00155	CcSEcCtD
Fluticasone furoate—Cough—Paclitaxel—kidney cancer	0.000233	0.00154	CcSEcCtD
Fluticasone furoate—Dyspnoea—Gemcitabine—kidney cancer	0.000232	0.00153	CcSEcCtD
Fluticasone furoate—Nausea—Vinblastine—kidney cancer	0.000231	0.00153	CcSEcCtD
Fluticasone furoate—Migraine—Doxorubicin—kidney cancer	0.000231	0.00153	CcSEcCtD
Fluticasone furoate—Nausea—Everolimus—kidney cancer	0.00023	0.00152	CcSEcCtD
Fluticasone furoate—Diarrhoea—Sorafenib—kidney cancer	0.00023	0.00152	CcSEcCtD
Fluticasone furoate—Immune system disorder—Capecitabine—kidney cancer	0.000227	0.0015	CcSEcCtD
Fluticasone furoate—Mediastinal disorder—Capecitabine—kidney cancer	0.000227	0.0015	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Dactinomycin—kidney cancer	0.000226	0.0015	CcSEcCtD
Fluticasone furoate—NR3C1—nephron tubule—kidney cancer	0.000225	0.0644	CbGeAlD
Fluticasone furoate—Dizziness—Sorafenib—kidney cancer	0.000223	0.00147	CcSEcCtD
Fluticasone furoate—Nausea—Erlotinib—kidney cancer	0.000222	0.00147	CcSEcCtD
Fluticasone furoate—Diarrhoea—Sunitinib—kidney cancer	0.000222	0.00147	CcSEcCtD
Fluticasone furoate—Anaphylactic shock—Paclitaxel—kidney cancer	0.000218	0.00144	CcSEcCtD
Fluticasone furoate—Body temperature increased—Vincristine—kidney cancer	0.000217	0.00143	CcSEcCtD
Fluticasone furoate—Infection—Paclitaxel—kidney cancer	0.000216	0.00143	CcSEcCtD
Fluticasone furoate—Dizziness—Sunitinib—kidney cancer	0.000214	0.00142	CcSEcCtD
Fluticasone furoate—Nervous system disorder—Paclitaxel—kidney cancer	0.000213	0.00141	CcSEcCtD
Fluticasone furoate—Rash—Sorafenib—kidney cancer	0.000212	0.0014	CcSEcCtD
Fluticasone furoate—Dermatitis—Sorafenib—kidney cancer	0.000212	0.0014	CcSEcCtD
Fluticasone furoate—Back pain—Capecitabine—kidney cancer	0.000212	0.0014	CcSEcCtD
Fluticasone furoate—Headache—Sorafenib—kidney cancer	0.000211	0.0014	CcSEcCtD
Fluticasone furoate—Diarrhoea—Dactinomycin—kidney cancer	0.00021	0.00139	CcSEcCtD
Fluticasone furoate—Nasopharyngitis—Doxorubicin—kidney cancer	0.000209	0.00139	CcSEcCtD
Fluticasone furoate—CYP3A4—Aflatoxin activation and detoxification—ACY1—kidney cancer	0.000207	0.0381	CbGpPWpGaD
Fluticasone furoate—Body temperature increased—Gemcitabine—kidney cancer	0.000205	0.00136	CcSEcCtD
Fluticasone furoate—Tremor—Capecitabine—kidney cancer	0.000205	0.00136	CcSEcCtD
Fluticasone furoate—NR3C1—renal system—kidney cancer	0.000204	0.0585	CbGeAlD
Fluticasone furoate—Rash—Sunitinib—kidney cancer	0.000204	0.00135	CcSEcCtD
Fluticasone furoate—Dermatitis—Sunitinib—kidney cancer	0.000204	0.00135	CcSEcCtD
Fluticasone furoate—Headache—Sunitinib—kidney cancer	0.000203	0.00134	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Vincristine—kidney cancer	0.000202	0.00134	CcSEcCtD
Fluticasone furoate—Nausea—Sorafenib—kidney cancer	0.0002	0.00132	CcSEcCtD
Fluticasone furoate—NR3C1—kidney—kidney cancer	0.000198	0.0566	CbGeAlD
Fluticasone furoate—NR3C1—Regulation of nuclear SMAD2/3 signaling—CITED1—kidney cancer	0.000196	0.0361	CbGpPWpGaD
Fluticasone furoate—Bronchitis—Doxorubicin—kidney cancer	0.000195	0.00129	CcSEcCtD
Fluticasone furoate—Dyspnoea—Paclitaxel—kidney cancer	0.000194	0.00128	CcSEcCtD
Fluticasone furoate—Palpitations—Capecitabine—kidney cancer	0.000193	0.00128	CcSEcCtD
Fluticasone furoate—Rash—Dactinomycin—kidney cancer	0.000193	0.00128	CcSEcCtD
Fluticasone furoate—Nausea—Sunitinib—kidney cancer	0.000192	0.00127	CcSEcCtD
Fluticasone furoate—NR3C1—cortex of kidney—kidney cancer	0.000192	0.0551	CbGeAlD
Fluticasone furoate—Cough—Capecitabine—kidney cancer	0.000191	0.00126	CcSEcCtD
Fluticasone furoate—Diarrhoea—Vincristine—kidney cancer	0.000187	0.00124	CcSEcCtD
Fluticasone furoate—NR3C1—gonad—kidney cancer	0.000183	0.0525	CbGeAlD
Fluticasone furoate—NR3C1—cardiac atrium—kidney cancer	0.000183	0.0524	CbGeAlD
Fluticasone furoate—Nausea—Dactinomycin—kidney cancer	0.000182	0.00121	CcSEcCtD
Fluticasone furoate—Dizziness—Vincristine—kidney cancer	0.000181	0.0012	CcSEcCtD
Fluticasone furoate—Diarrhoea—Gemcitabine—kidney cancer	0.000178	0.00118	CcSEcCtD
Fluticasone furoate—Infection—Capecitabine—kidney cancer	0.000177	0.00117	CcSEcCtD
Fluticasone furoate—Conjunctivitis—Doxorubicin—kidney cancer	0.000175	0.00116	CcSEcCtD
Fluticasone furoate—Nervous system disorder—Capecitabine—kidney cancer	0.000175	0.00116	CcSEcCtD
Fluticasone furoate—NR3C1—FOXA2 and FOXA3 transcription factor networks—HNF1A—kidney cancer	0.000175	0.0322	CbGpPWpGaD
Fluticasone furoate—Urticaria—Paclitaxel—kidney cancer	0.000173	0.00114	CcSEcCtD
Fluticasone furoate—Rash—Vincristine—kidney cancer	0.000173	0.00114	CcSEcCtD
Fluticasone furoate—Dermatitis—Vincristine—kidney cancer	0.000173	0.00114	CcSEcCtD
Fluticasone furoate—Body temperature increased—Paclitaxel—kidney cancer	0.000172	0.00114	CcSEcCtD
Fluticasone furoate—Headache—Vincristine—kidney cancer	0.000172	0.00114	CcSEcCtD
Fluticasone furoate—Epistaxis—Doxorubicin—kidney cancer	0.00017	0.00113	CcSEcCtD
Fluticasone furoate—NR3C1—AP-1 transcription factor network—FOSL2—kidney cancer	0.000167	0.0307	CbGpPWpGaD
Fluticasone furoate—Rash—Gemcitabine—kidney cancer	0.000164	0.00108	CcSEcCtD
Fluticasone furoate—Dermatitis—Gemcitabine—kidney cancer	0.000164	0.00108	CcSEcCtD
Fluticasone furoate—Triamcinolone—PTGS2—kidney cancer	0.000163	0.0431	CrCbGaD
Fluticasone furoate—Headache—Gemcitabine—kidney cancer	0.000163	0.00108	CcSEcCtD
Fluticasone furoate—Nausea—Vincristine—kidney cancer	0.000163	0.00108	CcSEcCtD
Fluticasone furoate—Pharyngitis—Doxorubicin—kidney cancer	0.000161	0.00106	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Paclitaxel—kidney cancer	0.00016	0.00106	CcSEcCtD
Fluticasone furoate—Connective tissue disorder—Doxorubicin—kidney cancer	0.000159	0.00105	CcSEcCtD
Fluticasone furoate—Dyspnoea—Capecitabine—kidney cancer	0.000159	0.00105	CcSEcCtD
Fluticasone furoate—Visual impairment—Doxorubicin—kidney cancer	0.000156	0.00103	CcSEcCtD
Fluticasone furoate—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—EGR1—kidney cancer	0.000155	0.0286	CbGpPWpGaD
Fluticasone furoate—CYP3A4—renal system—kidney cancer	0.000155	0.0443	CbGeAlD
Fluticasone furoate—Nausea—Gemcitabine—kidney cancer	0.000154	0.00102	CcSEcCtD
Fluticasone furoate—Eye disorder—Doxorubicin—kidney cancer	0.000151	0.001	CcSEcCtD
Fluticasone furoate—CYP3A4—kidney—kidney cancer	0.000149	0.0428	CbGeAlD
Fluticasone furoate—Diarrhoea—Paclitaxel—kidney cancer	0.000149	0.000986	CcSEcCtD
Fluticasone furoate—Immune system disorder—Doxorubicin—kidney cancer	0.000146	0.000969	CcSEcCtD
Fluticasone furoate—Mediastinal disorder—Doxorubicin—kidney cancer	0.000146	0.000967	CcSEcCtD
Fluticasone furoate—Dizziness—Paclitaxel—kidney cancer	0.000144	0.000953	CcSEcCtD
Fluticasone furoate—Urticaria—Capecitabine—kidney cancer	0.000142	0.000939	CcSEcCtD
Fluticasone furoate—NR3C1—Regulation of nuclear SMAD2/3 signaling—TFE3—kidney cancer	0.000142	0.0261	CbGpPWpGaD
Fluticasone furoate—Body temperature increased—Capecitabine—kidney cancer	0.000141	0.000934	CcSEcCtD
Fluticasone furoate—Rash—Paclitaxel—kidney cancer	0.000137	0.000908	CcSEcCtD
Fluticasone furoate—Dermatitis—Paclitaxel—kidney cancer	0.000137	0.000907	CcSEcCtD
Fluticasone furoate—NR3C1—Endoderm Differentiation—CER1—kidney cancer	0.000137	0.0251	CbGpPWpGaD
Fluticasone furoate—Back pain—Doxorubicin—kidney cancer	0.000136	0.000903	CcSEcCtD
Fluticasone furoate—Headache—Paclitaxel—kidney cancer	0.000136	0.000902	CcSEcCtD
Fluticasone furoate—Betamethasone—PTGS2—kidney cancer	0.000134	0.0353	CrCbGaD
Fluticasone furoate—Hypersensitivity—Capecitabine—kidney cancer	0.000132	0.000871	CcSEcCtD
Fluticasone furoate—CYP3A4—Fatty Acid Omega Oxidation—ALDH1A1—kidney cancer	0.00013	0.024	CbGpPWpGaD
Fluticasone furoate—Agitation—Doxorubicin—kidney cancer	0.00013	0.000858	CcSEcCtD
Fluticasone furoate—Nausea—Paclitaxel—kidney cancer	0.000129	0.000856	CcSEcCtD
Fluticasone furoate—Palpitations—Doxorubicin—kidney cancer	0.000125	0.000825	CcSEcCtD
Fluticasone furoate—Dexamethasone—CYP1A1—kidney cancer	0.000124	0.0329	CrCbGaD
Fluticasone furoate—Cough—Doxorubicin—kidney cancer	0.000123	0.000815	CcSEcCtD
Fluticasone furoate—Diarrhoea—Capecitabine—kidney cancer	0.000122	0.000809	CcSEcCtD
Fluticasone furoate—ABCB1—nephron tubule—kidney cancer	0.00012	0.0345	CbGeAlD
Fluticasone furoate—Dizziness—Capecitabine—kidney cancer	0.000118	0.000782	CcSEcCtD
Fluticasone furoate—Anaphylactic shock—Doxorubicin—kidney cancer	0.000115	0.000762	CcSEcCtD
Fluticasone furoate—Infection—Doxorubicin—kidney cancer	0.000114	0.000757	CcSEcCtD
Fluticasone furoate—Betamethasone—ABCB1—kidney cancer	0.000114	0.03	CrCbGaD
Fluticasone furoate—Nervous system disorder—Doxorubicin—kidney cancer	0.000113	0.000747	CcSEcCtD
Fluticasone furoate—Rash—Capecitabine—kidney cancer	0.000113	0.000745	CcSEcCtD
Fluticasone furoate—Dermatitis—Capecitabine—kidney cancer	0.000112	0.000745	CcSEcCtD
Fluticasone furoate—Headache—Capecitabine—kidney cancer	0.000112	0.000741	CcSEcCtD
Fluticasone furoate—NR3C1—AP-1 transcription factor network—FOSL1—kidney cancer	0.000111	0.0205	CbGpPWpGaD
Fluticasone furoate—ABCB1—renal system—kidney cancer	0.000109	0.0313	CbGeAlD
Fluticasone furoate—ABCB1—Allograft Rejection—HARS—kidney cancer	0.000107	0.0198	CbGpPWpGaD
Fluticasone furoate—Nausea—Capecitabine—kidney cancer	0.000106	0.000702	CcSEcCtD
Fluticasone furoate—ABCB1—kidney—kidney cancer	0.000106	0.0303	CbGeAlD
Fluticasone furoate—ABCB1—cortex of kidney—kidney cancer	0.000103	0.0295	CbGeAlD
Fluticasone furoate—Dyspnoea—Doxorubicin—kidney cancer	0.000103	0.000679	CcSEcCtD
Fluticasone furoate—NR3C1—Endoderm Differentiation—BMP7—kidney cancer	0.000101	0.0185	CbGpPWpGaD
Fluticasone furoate—NR3C1—Endoderm Differentiation—HNF1B—kidney cancer	0.000101	0.0185	CbGpPWpGaD
Fluticasone furoate—ABCB1—gonad—kidney cancer	9.81e-05	0.0281	CbGeAlD
Fluticasone furoate—CYP3A4—Aflatoxin B1 metabolism—GSTM1—kidney cancer	9.43e-05	0.0174	CbGpPWpGaD
Fluticasone furoate—Urticaria—Doxorubicin—kidney cancer	9.14e-05	0.000605	CcSEcCtD
Fluticasone furoate—Body temperature increased—Doxorubicin—kidney cancer	9.1e-05	0.000602	CcSEcCtD
Fluticasone furoate—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—BRAF—kidney cancer	8.95e-05	0.0165	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Codeine and Morphine Metabolism—ABCB1—kidney cancer	8.73e-05	0.0161	CbGpPWpGaD
Fluticasone furoate—NR3C1—AP-1 transcription factor network—JUND—kidney cancer	8.6e-05	0.0158	CbGpPWpGaD
Fluticasone furoate—Hypersensitivity—Doxorubicin—kidney cancer	8.48e-05	0.000561	CcSEcCtD
Fluticasone furoate—Diarrhoea—Doxorubicin—kidney cancer	7.88e-05	0.000521	CcSEcCtD
Fluticasone furoate—Dexamethasone—PTGS2—kidney cancer	7.77e-05	0.0205	CrCbGaD
Fluticasone furoate—Dizziness—Doxorubicin—kidney cancer	7.61e-05	0.000504	CcSEcCtD
Fluticasone furoate—CYP3A4—Irinotecan Pathway—BCHE—kidney cancer	7.41e-05	0.0136	CbGpPWpGaD
Fluticasone furoate—NR3C1—Adipogenesis—HNF1A—kidney cancer	7.36e-05	0.0135	CbGpPWpGaD
Fluticasone furoate—NR3C1—Adipogenesis—EPAS1—kidney cancer	7.36e-05	0.0135	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—kidney cancer	7.31e-05	0.0135	CbGpPWpGaD
Fluticasone furoate—Rash—Doxorubicin—kidney cancer	7.26e-05	0.00048	CcSEcCtD
Fluticasone furoate—Dermatitis—Doxorubicin—kidney cancer	7.25e-05	0.00048	CcSEcCtD
Fluticasone furoate—Headache—Doxorubicin—kidney cancer	7.21e-05	0.000477	CcSEcCtD
Fluticasone furoate—Nausea—Doxorubicin—kidney cancer	6.84e-05	0.000453	CcSEcCtD
Fluticasone furoate—NR3C1—Regulation of Androgen receptor activity—EGR1—kidney cancer	6.84e-05	0.0126	CbGpPWpGaD
Fluticasone furoate—Dexamethasone—ABCB1—kidney cancer	6.6e-05	0.0175	CrCbGaD
Fluticasone furoate—ABCB1—HIF-1-alpha transcription factor network—PGK1—kidney cancer	6.52e-05	0.012	CbGpPWpGaD
Fluticasone furoate—NR3C1—Glucocorticoid receptor regulatory network—IL13—kidney cancer	6.36e-05	0.0117	CbGpPWpGaD
Fluticasone furoate—ABCB1—Allograft Rejection—LRRK2—kidney cancer	6.17e-05	0.0114	CbGpPWpGaD
Fluticasone furoate—ABCB1—HIF-1-alpha transcription factor network—NDRG1—kidney cancer	6.06e-05	0.0112	CbGpPWpGaD
Fluticasone furoate—NR3C1—AP-1 transcription factor network—JUNB—kidney cancer	5.85e-05	0.0108	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Tryptophan metabolism—ALDH1A1—kidney cancer	5.59e-05	0.0103	CbGpPWpGaD
Fluticasone furoate—ABCB1—HIF-1-alpha transcription factor network—CA9—kidney cancer	5.54e-05	0.0102	CbGpPWpGaD
Fluticasone furoate—NR3C1—AP-1 transcription factor network—EGR1—kidney cancer	5.47e-05	0.0101	CbGpPWpGaD
Fluticasone furoate—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK3—kidney cancer	5.39e-05	0.00992	CbGpPWpGaD
Fluticasone furoate—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK1—kidney cancer	5.13e-05	0.00944	CbGpPWpGaD
Fluticasone furoate—NR3C1—Glucocorticoid receptor regulatory network—EGR1—kidney cancer	4.82e-05	0.00888	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—kidney cancer	4.78e-05	0.0088	CbGpPWpGaD
Fluticasone furoate—NR3C1—Circadian Clock—HIF1A—kidney cancer	4.62e-05	0.0085	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—kidney cancer	4.62e-05	0.0085	CbGpPWpGaD
Fluticasone furoate—NR3C1—SIDS Susceptibility Pathways—HSPD1—kidney cancer	4.53e-05	0.00834	CbGpPWpGaD
Fluticasone furoate—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—FLT1—kidney cancer	4.51e-05	0.0083	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Estrogen metabolism—GSTM1—kidney cancer	4.43e-05	0.00816	CbGpPWpGaD
Fluticasone furoate—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN2B—kidney cancer	4.24e-05	0.0078	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Estrogen metabolism—CYP1A1—kidney cancer	4.2e-05	0.00773	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Irinotecan Pathway—APC—kidney cancer	4.02e-05	0.00741	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Xenobiotics—CYP1A1—kidney cancer	3.86e-05	0.00711	CbGpPWpGaD
Fluticasone furoate—NR3C1—AP-1 transcription factor network—HIF1A—kidney cancer	3.81e-05	0.00701	CbGpPWpGaD
Fluticasone furoate—NR3C1—SIDS Susceptibility Pathways—IL13—kidney cancer	3.8e-05	0.007	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Tamoxifen metabolism—CYP1A1—kidney cancer	3.71e-05	0.00684	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Phase 1 - Functionalization of compounds—ALDH1A1—kidney cancer	3.66e-05	0.00674	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Biological oxidations—ACY1—kidney cancer	3.55e-05	0.00654	CbGpPWpGaD
Fluticasone furoate—ABCB1—Allograft Rejection—IL13—kidney cancer	3.52e-05	0.00648	CbGpPWpGaD
Fluticasone furoate—NR3C1—Endoderm Differentiation—APC—kidney cancer	3.43e-05	0.00632	CbGpPWpGaD
Fluticasone furoate—ABCB1—HIF-1-alpha transcription factor network—SLC2A1—kidney cancer	3.32e-05	0.00611	CbGpPWpGaD
Fluticasone furoate—NR3C1—SIDS Susceptibility Pathways—EGR1—kidney cancer	2.88e-05	0.00531	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—kidney cancer	2.88e-05	0.0053	CbGpPWpGaD
Fluticasone furoate—NR3C1—Regulation of Androgen receptor activity—JUN—kidney cancer	2.87e-05	0.00528	CbGpPWpGaD
Fluticasone furoate—NR3C1—Glucocorticoid receptor regulatory network—POMC—kidney cancer	2.81e-05	0.00518	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—kidney cancer	2.74e-05	0.00505	CbGpPWpGaD
Fluticasone furoate—NR3C1—AP-1 transcription factor network—CDKN2A—kidney cancer	2.72e-05	0.00501	CbGpPWpGaD
Fluticasone furoate—NR3C1—AP-1 transcription factor network—CDKN1B—kidney cancer	2.41e-05	0.00444	CbGpPWpGaD
Fluticasone furoate—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—kidney cancer	2.4e-05	0.00441	CbGpPWpGaD
Fluticasone furoate—NR3C1—AP-1 transcription factor network—IL2—kidney cancer	2.36e-05	0.00435	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—HARS—kidney cancer	2.36e-05	0.00435	CbGpPWpGaD
Fluticasone furoate—NR3C1—Endoderm Differentiation—CTNNB1—kidney cancer	2.33e-05	0.00429	CbGpPWpGaD
Fluticasone furoate—NR3C1—Adipogenesis—HIF1A—kidney cancer	2.32e-05	0.00427	CbGpPWpGaD
Fluticasone furoate—NR3C1—Glucocorticoid receptor regulatory network—RELA—kidney cancer	2.31e-05	0.00425	CbGpPWpGaD
Fluticasone furoate—NR3C1—AP-1 transcription factor network—CCND1—kidney cancer	2.3e-05	0.00424	CbGpPWpGaD
Fluticasone furoate—NR3C1—AP-1 transcription factor network—JUN—kidney cancer	2.3e-05	0.00423	CbGpPWpGaD
Fluticasone furoate—NR3C1—AP-1 transcription factor network—CTNNB1—kidney cancer	2.28e-05	0.0042	CbGpPWpGaD
Fluticasone furoate—NR3C1—AP-1 transcription factor network—PTEN—kidney cancer	2.22e-05	0.00409	CbGpPWpGaD
Fluticasone furoate—ABCB1—HIF-1-alpha transcription factor network—HIF1A—kidney cancer	2.14e-05	0.00395	CbGpPWpGaD
Fluticasone furoate—NR3C1—Glucocorticoid receptor regulatory network—IL2—kidney cancer	2.08e-05	0.00383	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—JUND—kidney cancer	2.07e-05	0.00381	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—APAF1—kidney cancer	2.07e-05	0.00381	CbGpPWpGaD
Fluticasone furoate—NR3C1—Regulation of nuclear SMAD2/3 signaling—JUN—kidney cancer	2.04e-05	0.00376	CbGpPWpGaD
Fluticasone furoate—NR3C1—Glucocorticoid receptor regulatory network—JUN—kidney cancer	2.02e-05	0.00373	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	2.02e-05	0.00371	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—EIF5B—kidney cancer	2.01e-05	0.00369	CbGpPWpGaD
Fluticasone furoate—NR3C1—SIDS Susceptibility Pathways—HIF1A—kidney cancer	2.01e-05	0.00369	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Tryptophan metabolism—CYP1A1—kidney cancer	1.98e-05	0.00365	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—kidney cancer	1.96e-05	0.00361	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Biological oxidations—ALDH1A1—kidney cancer	1.95e-05	0.00358	CbGpPWpGaD
Fluticasone furoate—ABCB1—Transmembrane transport of small molecules—RYR1—kidney cancer	1.93e-05	0.00354	CbGpPWpGaD
Fluticasone furoate—NR3C1—AP-1 transcription factor network—MYC—kidney cancer	1.85e-05	0.0034	CbGpPWpGaD
Fluticasone furoate—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—kidney cancer	1.72e-05	0.00317	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—ACHE—kidney cancer	1.71e-05	0.00314	CbGpPWpGaD
Fluticasone furoate—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—kidney cancer	1.67e-05	0.00308	CbGpPWpGaD
Fluticasone furoate—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—kidney cancer	1.64e-05	0.00302	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	1.6e-05	0.00295	CbGpPWpGaD
Fluticasone furoate—NR3C1—Glucocorticoid receptor regulatory network—MAPK1—kidney cancer	1.59e-05	0.00293	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	1.58e-05	0.00291	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—ANXA1—kidney cancer	1.57e-05	0.00289	CbGpPWpGaD
Fluticasone furoate—NR3C1—AP-1 transcription factor network—TP53—kidney cancer	1.52e-05	0.00279	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—JUNB—kidney cancer	1.41e-05	0.00259	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—PAK1—kidney cancer	1.41e-05	0.00259	CbGpPWpGaD
Fluticasone furoate—NR3C1—Adipogenesis—CTNNB1—kidney cancer	1.39e-05	0.00256	CbGpPWpGaD
Fluticasone furoate—NR3C1—Glucocorticoid receptor regulatory network—TP53—kidney cancer	1.34e-05	0.00246	CbGpPWpGaD
Fluticasone furoate—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—kidney cancer	1.32e-05	0.00243	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—EGR1—kidney cancer	1.32e-05	0.00242	CbGpPWpGaD
Fluticasone furoate—NR3C1—Generic Transcription Pathway—JUNB—kidney cancer	1.3e-05	0.0024	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	1.3e-05	0.00239	CbGpPWpGaD
Fluticasone furoate—ABCB1—HIF-1-alpha transcription factor network—JUN—kidney cancer	1.29e-05	0.00238	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—EEF2—kidney cancer	1.29e-05	0.00238	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—TET2—kidney cancer	1.24e-05	0.00228	CbGpPWpGaD
Fluticasone furoate—NR3C1—SIDS Susceptibility Pathways—JUN—kidney cancer	1.21e-05	0.00223	CbGpPWpGaD
Fluticasone furoate—NR3C1—SIDS Susceptibility Pathways—CTNNB1—kidney cancer	1.2e-05	0.00221	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	1.2e-05	0.0022	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—kidney cancer	1.16e-05	0.00213	CbGpPWpGaD
Fluticasone furoate—ABCB1—Allograft Rejection—IL2—kidney cancer	1.15e-05	0.00212	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—kidney cancer	1.15e-05	0.00211	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Biological oxidations—GSTT1—kidney cancer	1.14e-05	0.00211	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—TCEB2—kidney cancer	1.13e-05	0.00209	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—TCEB1—kidney cancer	1.13e-05	0.00209	CbGpPWpGaD
Fluticasone furoate—ABCB1—HIF-1-alpha transcription factor network—VEGFA—kidney cancer	1.13e-05	0.00208	CbGpPWpGaD
Fluticasone furoate—ABCB1—Transmembrane transport of small molecules—ANXA2—kidney cancer	1.11e-05	0.00204	CbGpPWpGaD
Fluticasone furoate—ABCB1—Transmembrane transport of small molecules—SLC5A3—kidney cancer	1.11e-05	0.00204	CbGpPWpGaD
Fluticasone furoate—ABCB1—Transmembrane transport of small molecules—ATP7B—kidney cancer	1.11e-05	0.00204	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Biological oxidations—PTGS1—kidney cancer	1.07e-05	0.00197	CbGpPWpGaD
Fluticasone furoate—NR3C1—Generic Transcription Pathway—CDKN2B—kidney cancer	1.06e-05	0.00195	CbGpPWpGaD
Fluticasone furoate—NR3C1—SIDS Susceptibility Pathways—VEGFA—kidney cancer	1.06e-05	0.00195	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—ACY1—kidney cancer	9.86e-06	0.00182	CbGpPWpGaD
Fluticasone furoate—ABCB1—Allograft Rejection—VEGFA—kidney cancer	9.78e-06	0.0018	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	9.69e-06	0.00178	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—RPL14—kidney cancer	9.21e-06	0.0017	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—PDHB—kidney cancer	8.38e-06	0.00154	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	8.07e-06	0.00149	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Biological oxidations—GSTP1—kidney cancer	7.93e-06	0.00146	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—CCBL1—kidney cancer	7.88e-06	0.00145	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	7.82e-06	0.00144	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—EIF4EBP1—kidney cancer	7.51e-06	0.00138	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—HSPB1—kidney cancer	7.51e-06	0.00138	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Biological oxidations—GSTM1—kidney cancer	7.28e-06	0.00134	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	7.18e-06	0.00132	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—PSMD7—kidney cancer	6.98e-06	0.00129	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	6.91e-06	0.00127	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—PPAT—kidney cancer	6.83e-06	0.00126	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—GLIPR1—kidney cancer	6.83e-06	0.00126	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	6.81e-06	0.00125	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—FH—kidney cancer	6.35e-06	0.00117	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—APRT—kidney cancer	6.35e-06	0.00117	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	6.34e-06	0.00117	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—JUNB—kidney cancer	6.27e-06	0.00115	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	6.27e-06	0.00115	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	6.13e-06	0.00113	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—ACY1—kidney cancer	6.07e-06	0.00112	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—GPC3—kidney cancer	5.97e-06	0.0011	CbGpPWpGaD
Fluticasone furoate—ABCB1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	5.83e-06	0.00107	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—CA2—kidney cancer	5.81e-06	0.00107	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	5.81e-06	0.00107	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—ALAD—kidney cancer	5.66e-06	0.00104	CbGpPWpGaD
Fluticasone furoate—ABCB1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	5.63e-06	0.00104	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	5.54e-06	0.00102	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—ST3GAL2—kidney cancer	5.53e-06	0.00102	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	5.53e-06	0.00102	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	5.48e-06	0.00101	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—ALDH1A1—kidney cancer	5.4e-06	0.000994	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	5.35e-06	0.000984	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—SLC5A3—kidney cancer	5.18e-06	0.000953	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—PGK1—kidney cancer	5.18e-06	0.000953	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—PDHB—kidney cancer	5.16e-06	0.000951	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Biological oxidations—POMC—kidney cancer	5.15e-06	0.000948	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—CDKN2B—kidney cancer	5.1e-06	0.000939	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—LDHB—kidney cancer	5.08e-06	0.000935	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—CCBL1—kidney cancer	4.86e-06	0.000894	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	4.83e-06	0.000889	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	4.57e-06	0.000841	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	4.44e-06	0.000818	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—CA9—kidney cancer	4.4e-06	0.000811	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	4.35e-06	0.0008	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—PPAT—kidney cancer	4.21e-06	0.000775	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—GLIPR1—kidney cancer	4.21e-06	0.000775	CbGpPWpGaD
Fluticasone furoate—NR3C1—Generic Transcription Pathway—MYC—kidney cancer	4.11e-06	0.000756	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	4.1e-06	0.000756	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—APRT—kidney cancer	3.91e-06	0.000721	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—FH—kidney cancer	3.91e-06	0.000721	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	3.77e-06	0.000694	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—CRABP1—kidney cancer	3.74e-06	0.000689	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—GPC3—kidney cancer	3.68e-06	0.000678	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	3.65e-06	0.000672	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—CA2—kidney cancer	3.58e-06	0.000659	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—ALAD—kidney cancer	3.49e-06	0.000642	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—ITPR2—kidney cancer	3.48e-06	0.000641	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—ST3GAL2—kidney cancer	3.4e-06	0.000627	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—ALDH1A1—kidney cancer	3.33e-06	0.000613	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—SLC5A3—kidney cancer	3.19e-06	0.000587	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—PGK1—kidney cancer	3.19e-06	0.000587	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—GSTT1—kidney cancer	3.17e-06	0.000584	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—ACHE—kidney cancer	3.17e-06	0.000584	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—LDHB—kidney cancer	3.13e-06	0.000576	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—SCARB1—kidney cancer	3e-06	0.000553	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—PTGS1—kidney cancer	2.97e-06	0.000548	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—PSMD7—kidney cancer	2.92e-06	0.000537	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—BCHE—kidney cancer	2.77e-06	0.000509	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—SLC5A5—kidney cancer	2.73e-06	0.000503	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—CA9—kidney cancer	2.71e-06	0.000499	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—SLC2A1—kidney cancer	2.64e-06	0.000486	CbGpPWpGaD
Fluticasone furoate—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	2.52e-06	0.000463	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—CRABP1—kidney cancer	2.31e-06	0.000425	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—GSTP1—kidney cancer	2.2e-06	0.000405	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—ITPR2—kidney cancer	2.14e-06	0.000395	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—MAPK3—kidney cancer	2.03e-06	0.000374	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—GSTM1—kidney cancer	2.02e-06	0.000372	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—MYC—kidney cancer	1.98e-06	0.000364	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—ACHE—kidney cancer	1.96e-06	0.00036	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—GSTT1—kidney cancer	1.96e-06	0.00036	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—CYP1A1—kidney cancer	1.92e-06	0.000353	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—SCARB1—kidney cancer	1.85e-06	0.000341	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—PTGS1—kidney cancer	1.83e-06	0.000337	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—PSMD7—kidney cancer	1.8e-06	0.000331	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—BCHE—kidney cancer	1.7e-06	0.000314	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—SLC5A5—kidney cancer	1.68e-06	0.00031	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—SLC2A1—kidney cancer	1.63e-06	0.000299	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—POMC—kidney cancer	1.43e-06	0.000263	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—GSTP1—kidney cancer	1.36e-06	0.00025	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—ABCB1—kidney cancer	1.28e-06	0.000236	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—GSTM1—kidney cancer	1.25e-06	0.000229	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—CYP1A1—kidney cancer	1.18e-06	0.000217	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—PTGS2—kidney cancer	1.14e-06	0.00021	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—PTEN—kidney cancer	9.94e-07	0.000183	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—POMC—kidney cancer	8.8e-07	0.000162	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—PTGS2—kidney cancer	7.02e-07	0.000129	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—PIK3CA—kidney cancer	7.01e-07	0.000129	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—PTEN—kidney cancer	6.12e-07	0.000113	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—PIK3CA—kidney cancer	4.32e-07	7.95e-05	CbGpPWpGaD
